Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler. This is an increase from 50 implants within its first quarter of market availability, as reported in January 2018.
OsteoCrete is resorbable, injectable, moldable and biocompatible, and cleared for procedures such as complex sport-related injuries and musculoskeletal extremities trauma. The product is reported to be the first in the U.S. to incorporate magnesium rather than calcium to support bone health and development.
Source: Bone Solutions Inc.
Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler. This is an increase from 50 implants within its first quarter of market availability, as reported in January 2018.
OsteoCrete is resorbable, injectable, moldable and biocompatible, and cleared for procedures such as complex...
Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler. This is an increase from 50 implants within its first quarter of market availability, as reported in January 2018.
OsteoCrete is resorbable, injectable, moldable and biocompatible, and cleared for procedures such as complex sport-related injuries and musculoskeletal extremities trauma. The product is reported to be the first in the U.S. to incorporate magnesium rather than calcium to support bone health and development.
Source: Bone Solutions Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.